Skip to content

Single-joint hybrid assistive limb as a new therapeutic device for active-assistive muscle activity-guided rehabilitation of knee joint injury-a randomized controlled clinical trial.

Single-joint hybrid assistive limb as a new therapeutic device for active-assistive muscle activity-guided rehabilitation of knee joint injury-a randomized controlled clinical trial.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031324
Enrollment
120
Registered
2023-06-28
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary knee TEP Fractures near the knee joint Knee ligaments/tendon injuries M17 S83 S72.4 S82.1

Interventions

Group 1: Intervention group: Training with SJ-HAL. Training using the SJ-HAL takes place 5 days a week for a total of 3 weeks. Each session lasts about 30 minutes. Group 2: Control group: Training wit

Sponsors

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 69 Years

Inclusion criteria

Inclusion criteria: -implantation of primary knee TEP, performance of KSR or BGSW -Surgery after fractures close to the knee joint, KSR or BGSW performed -Surgery after knee ligament/tendon injuries, performance of KSR or BGSW

Exclusion criteria

Exclusion criteria: -American Society of Anesthesiologists (ASA)-Score > III (classification for the physical status of the patient) -Neurological deficits -Patients with pacemakers -Skin diseases that are aggravated by sticking of the electrodes are -Extensive edema of the lower extremity -patients with severe pain that makes conventional rehabilitation impossible rehabilitation impossible -Rejection by patients

Design outcomes

Primary

MeasureTime frame
Survey of knee joint range of motion, strength (extension/flexion) after 3 weeks, 6 and 12 months

Secondary

MeasureTime frame
Survey Visual Analgesia Scale, lower extremity circumferences, Oxford Knee Score, EQ5D at 3 weeks, 6 and 12 months.

Countries

Germany

Contacts

Public ContactSilvia Hufnagel

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH

silvia.hufnagel@bergmannsheil.de02343023250

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026